# Pfizer Inc. (PFE) — Q3-2015 Earnings Results

**Report date:** 2015-10-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2015

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 2.43%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.60 | N/A | +17.88% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a positive outlook on product performance, emphasizing their commitment to innovation. They also acknowledged the challenges in the market.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They noted ongoing investments in research and development.

> There was an emphasis on maintaining operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's strong EPS performance, exceeding expectations by nearly 18%, contributed to a positive stock reaction, with shares rising 2.43%. The company continues to focus on product development and operational efficiency, which may bode well for future performance. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2015_